Catherine R. Aversa

Catherine R. Aversa has a strong background in translational research and medicine. Catherine R. has held various senior positions at different biotech and pharmaceutical companies. Currently, they are working as the Senior Director of Translational Research at AnaptysBio. Prior to that, they served as the Senior Director of Translational Medicine at Invenra and the Senior Director of Translational Biology at Xencor. Catherine R. also held the position of Director of Translational Science at Biosplice Therapeutics. Aversa gained extensive experience during their time at Pfizer, where they worked as the Director of Translational Oncology and Senior Principal Scientist and Lab Head. Catherine R. began their career at Bristol-Myers Squibb, where they held various roles including Senior Research Investigator and Associate Research Scientist. Additionally, they worked as a Research Biochemist at Merck and as a Staff Scientist at Quality Biotech Inc. Aversa has expertise in developing comprehensive biomarker strategies, analyzing high content data, and overseeing the development of biomarker assays.

Catherine R. Aversa holds a Master of Science (M.S.) degree in Molecular Biology from Lehigh University. Catherine R. also received their Bachelor of Arts (B.A.) degree in Biology from Rosemont College. However, no specific start or end years were provided for either of their educational experiences.